Cas:130771-16-3 [methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate manufacturer & supplier

We serve Chemical Name:[methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate CAS:130771-16-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

[methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate

Chemical Name:[methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate
CAS.NO:130771-16-3
Synonyms:[methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate
Molecular Formula:C8H16O3Si
Molecular Weight:188.29600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:190ºC
Density:0.955 g/cm3
Index of Refraction:
PSA:35.53000
Exact Mass:188.08700
LogP:1.91470

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like [methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate Use and application,[methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate technical grade,usp/ep/jp grade.


Related News: What is the difference? Raw material refers to chemical compounds that are used as a base to make an API. [methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate manufacturer Any drug or medication is composed of two components. [methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate supplier Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. [methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate vendor One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. [methoxy(dimethyl)silyl]methyl 2-methylprop-2-enoate factory What is the difference? Raw material refers to chemical compounds that are used as a base to make an API.